GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Taro Pharmaceutical Industries Ltd (FRA:TAL) » Definitions » Stock Based Compensation

Taro Pharmaceutical Industries (FRA:TAL) Stock Based Compensation : €0.0 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Taro Pharmaceutical Industries Stock Based Compensation?

Taro Pharmaceutical Industries's Stock Based Compensation for the three months ended in Mar. 2024 was €0.0 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 was €0.0 Mil.


Taro Pharmaceutical Industries Stock Based Compensation Historical Data

The historical data trend for Taro Pharmaceutical Industries's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Taro Pharmaceutical Industries Stock Based Compensation Chart

Taro Pharmaceutical Industries Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Stock Based Compensation
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Taro Pharmaceutical Industries Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Stock Based Compensation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Taro Pharmaceutical Industries Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

Stock Based Compensation for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.


Taro Pharmaceutical Industries Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Taro Pharmaceutical Industries's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Taro Pharmaceutical Industries (FRA:TAL) Business Description

Traded in Other Exchanges
Address
14 Hakitor Street, P.O. Box 10347, Haifa Bay, Haifa, ISR, 2624761
Taro Pharmaceutical Industries Ltd produces, researches, develops, and markets pharmaceutical products. Its primary focus includes semi-solid formulations, such as creams and ointments, and other dosage forms such as liquids, capsules, and tablets. The company is engaged in the dermatological and topical, cardiovascular, neuropsychiatric, and anti-inflammatory therapeutic categories. Geographically, it derives a majority of its revenue from the United States and also has a presence in Canada, Israel, and Other Countries.

Taro Pharmaceutical Industries (FRA:TAL) Headlines

From GuruFocus